eps of it banking companies

8/13/2019 eps of it banking companies

1/35

SELECTION OF THE COMPANIES

Now we will select 2 companies from each sector namely Banking, Information technology

& pharmaceuticals on the basis of EPS(Earning per share) of each company in the year 2012.

1. Banking sector:-In banking sector we have divided whole sector in two sub-sectors. Public and private

sector.

And we will select one company each from both sectors. As it will help us to reduce

our risk in investment by diversifying it.

Private sector

BankEps(inRs)

Jammu &Kashmir Bank 217.65Axis Bank 110.56

ICICI Bank 72.16

Karur Vysya 51.34

ING Vysya Bank 39.52

As jammu & Kashmir bank is having highest Eps in private sector with 217.65 Rs. we will

select jammu and Kashmir bank from banking sector.

SBI is having highest EPS in private banking sector with Rs 206.20. so, we will select Statebank of India from private banking sector.

2. Pharmaceutical sector:-Pharmaceutical

companyEps(InRs)

Pfizer 168.62

Sanofi India 78.55

Dr Reddys Labs 74.51

GlaxoSmithKline 73.6

Abbott India 70.27

Torrent Pharma 64.59

Wyeth 57.24

Wockhardt 56.83

Venus Remedies 54.21

Sharon Bio Medi 48.82

Public sector

Bank

Eps(In

Rs)SBI 206.2

PNB 134.31

State Bank of Travancore 123.01

Bank of Baroda 106.05

State Bank of Bikaner andJaipur 104.32
http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/pfizer/Phttp://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/pfizer/Phttp://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/aventispharma/AP26http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/drreddyslaboratories/DRLhttp://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/drreddyslaboratories/DRLhttp://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/glaxosmithklinepharmaceuticals/GSKhttp://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/abbottindia/AI51http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/abbottindia/AI51http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/torrentpharmaceuticals/TP06http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/torrentpharmaceuticals/TP06http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/wyeth/W11http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/wyeth/W11http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/wockhardt/W05http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/venusremedies/VR01http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/venusremedies/VR01http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/sharonbiomedicine/SBM01http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/sharonbiomedicine/SBM01http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/sharonbiomedicine/SBM01http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/venusremedies/VR01http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/wockhardt/W05http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/wyeth/W11http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/torrentpharmaceuticals/TP06http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/abbottindia/AI51http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/glaxosmithklinepharmaceuticals/GSKhttp://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/drreddyslaboratories/DRLhttp://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/aventispharma/AP26http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/pfizer/P


2/35

As we can see in the above table different Pharma companies with their EPS in previous

year. We will select first two companies with higher EPS. So, we will select Pfizer with

EPS of 168.62 Rs and sanofi India with EPS of 78.55 Rs.

3. Information technology sector:-Information technology

CompanyEps (InRs)

Infosys 158.75

OracleFinancial 122.43

Financial Tech 70.07

TCS 65.15

Tech Mahindra 50.81

Persistent 45.45

HCL Tech 41.89

HindujaVenture 37.34

MphasiS 28.86

Zensar Tech 27.89

As we can see in the above table different IT companies with their EPS in previous year. We

will select first two companies with higher EPS. So, we will select Infosys with EPS of

158.75 Rs and Oracle Financial with EPS of 122.43 Rs.


3/35

BANKING INDUSTRY

The word bank is derived from the Italian banca,which is derived from

German and means bench. The terms bankrupt and "broke" are similarly derived from

banca rotta, which refers to an out of business bank, having its bench physically broken.

Moneylenders in Northern Italy originally did business in open areas, or big open rooms,

with each lender working from his own bench or table.

Typically, a bank generates profits from transaction fees on financial

services or the interest spread on resources it holds in trust for clients while paying them

interest on the asset. Development of banking industry in India followed below stated steps.

Banking in India has its origin as early as the Vedic period. It is believed that thetransistion from money lending to banking must have occurred even before Manu, the

great Hindu Jurist, who has devoted a section of his work to deposits and advances

and laid down rules relating to rates of interest.

Banking in India has an early origin where the indigenous bankers played a veryimportant role in lending money and financing foreign trade and commerce. Duringthe days of the East India Company, was the turn of the agency houses to carry on the

banking business. The General Bank of India was first Joint Stock Bank to be

established in the year 1786. The others which followed were the Bank Hindustan and

the Bengal Bank.

In the first half of the 19th century the East India Company established three banks;the Bank of Bengal in 1809, the Bank of Bombay in 1840 and the Bank of Madras in

1843. These three banks also known as Presidency banks were amalgamated in 1920

and a new bank, the Imperial Bank of India was established in 1921. With the passing

of the State Bank of India Act in 1955 the undertaking of the Imperial Bank of India

was taken by the newly constituted State Bank of India.

The Reserve Bank of India which is the Central Bank was created in 1935 by passingReserve Bank of India Act, 1934 which was followed up with the Banking


4/35

Regulations in 1949. These acts bestowed Reserve Bank of India (RBI) with wide

ranging powers for licensing, supervision and control of banks. Considering the

proliferation of weak banks, RBI compulsorily merged many of them with stronger

banks in 1969.

The three decades after nationalization saw a phenomenal expansion in thegeographical coverage and financial spread of the banking system in the country. As

certain rigidities and weaknesses were found to have developed in the system, during

the late eighties the Government of India felt that these had to be addressed to enable

the financial system to play its role in ushering in a more efficient and competitive

economy. Accordingly, a high-level committee was set up on 14 August 1991 to

examine all aspects relating to the structure, organization, functions and procedures of

the financial system. Based on the recommendations of the Committee (Chairman:

Shri M. Narasimham), a comprehensive reform of the banking system was introduced

in 1992-93. The objective of the reform measures was to ensure that the balance

sheets of banks reflected their actual financial health. One of the important measures

related to income recognition, asset classification and provisioning by banks, on the

basis of objective criteria was laid down by the Reserve Bank. The introduction of

capital adequacy norms in line with international standards has been another

important measure of the reforms process.

1.Comprises balance of expired loans, compensation and other bonds such as National

Rural Development Bonds and Capital Investment Bonds. Annuity certificates are

excluded.

2. These represent mainly non- negotiable non- interest bearing securities issued to

International Financial Institutions like International Monetary Fund, International

Bank for Reconstruction and Development and Asian Development Bank.

3. At book value.

4.Comprises accruals under Small Savings Scheme, Provident Funds, Special

Deposits of Non- Government


5/35

In the post-nationalization era, no new private sector banks were allowed to be setup. However, in 1993, in recognition of the need to introduce greater competition

which could lead to higher productivity and efficiency of the banking system, new

private sector banks were allowed to be set up in the Indian banking system. These

new banks had to satisfy among others, the following minimum requirements:

(i) It should be registered as a public limited company;(ii)The minimum paid-up capital should be Rs 100 crore;(iii) The shares should be listed on the stock exchange;(iv) The headquarters of the bank should be preferably located in a centre which

does not have the headquarters of any other bank; and

(v) The bank will be subject to prudential norms in respect of banking operations,accounting and other policies as laid down by the RBI. It will have to achieve

capital adequacy of eight per cent from the very beginning.

Indian Banking: Key Developments

1969 Government acquires ownership in major banks Almost all banking operations in manual mode Some banks had Unit record Machines of IBM for IBR & Pay roll

1970- 1980 Unprecedented expansion in geographical coverage, staff, business& transaction volumes and directed lending to agriculture, SSI &

SB sector

Manual systems struggle to handle exponential rise in transactionvolumes --

Outsourcing of data processing to service bureaux begins Back office systems only in Multinational (MNC) banks' offices

1981- 1990 Regulator (read RBI) led IT introduction in Banks Product level automation on stand alone PCs at branches (ALPMs) In-house EDP infrastructure with Unix boxes, batch processing in

Cobol for MIS.

Mainframes in corporate office


6/35

1991-1995 Expansion slows down Banking sector reforms resulting in progressive de-regulation of

banking, introduction of prudential banking norms entry of new

private sector banks

New private banks are set up with CBS/TBA form the start1996-2000 New delivery channels like ATM, Phone banking and Internet

banking and convenience of any branch banking and auto sweep

products introduced by new private and MNC banks

Retail banking in focus, proliferation of credit cards Communication infrastructure improves and becomes cheap.

IDRBT sets up VSAT network for Banks

2000-2003 Alternate delivery channels find wide consumer acceptance IT Bill passed lending legal validity to electronic transactions Govt. owned banks and old private banks start implementing

CBSs, but initial attempts face problems

Banks enter insurance business launch debit cards


7/35

JAMMU AND KASHMIR BANK

The Jammu and Kashmir Bankwas founded on October 1, 1938 under letters patent issued

by theMaharaja of Jammu and Kashmir,Hari Singh.The Maharaja invited eminent Kashmiri

investors to become founding directors and shareholders of the bank, the most notable of

which were Abdul Aziz Mantoo, Pesten Gee and the Bhaghat Family, all of whom acquired

major shareholdings.

The Bank commenced business on July 4, 1939 and was considered the first of its nature and

composition as a State owned bank in the country. The Bank was established as a semi-State

Bank with participation in capital by State and the public under the control of State

Government. In 1971, the Bank acquired the status of a scheduled bank and was declared as

an "A" Class bank by the Reserve Bank of India in 1976.

The bank had to face serious problems at the time of independence when out of its total of ten

branches two branches ofMuzaffarabad,RawalakotandMirpur fell to the other side of the

line of control (nowPakistan-administered Kashmir) along with cash and other assets.

Following the extension of Central laws to the state of Jammu & Kashmir, the bank was

defined as a government company as per the provisions of Indian companies act 1956.

Mushtaq Ahmed is the new Chairman & CEO of Jammu & Kashmir Bank.

J&K Banks Annual Report 2008-09 has won three awards at the prestigious LACP 2009

Vision Awards the worlds largest award programme for Annual Reports, organized by

California-based League of American Communications Professionals (LACP), USA. The

LACP is a forum within the public relations industry that facilitates discussion of best-in-

class practices in public relations and recognizes exemplary communication capabilities at a

global level. The awards received includeRank 73 on the top hundred list of annual reports

from around the world, Platinum Award in the Commercial Banks Up to $10 billion annual

revenue from the Asia Pacific Region and Silver Award for Most Creative Report across all

sectors from the Asia Pacific Region. DrHaseeb Drabu was chairman and chief executive of

the bank for the period 2005 to 2010.

The bank is celebrating its platinum jubilee this fiscal year (FY13). To make this year

remarkable, the bank aims to achieve a total business of Rs 100000 crore and earn a net profit

of Rs 1,000 crore. On April 1, 2013 the bank surpassed the target of promised Rs 100000
http://en.wikipedia.org/wiki/Maharaja_of_Jammu_and_Kashmirhttp://en.wikipedia.org/wiki/Hari_Singhhttp://en.wikipedia.org/wiki/Muzaffarabadhttp://en.wikipedia.org/wiki/Rawalakothttp://en.wikipedia.org/wiki/Mirpur,_Azad_Kashmirhttp://en.wikipedia.org/wiki/Azad_Kashmirhttp://en.wikipedia.org/wiki/Haseeb_Drabuhttp://en.wikipedia.org/wiki/Haseeb_Drabuhttp://en.wikipedia.org/wiki/Azad_Kashmirhttp://en.wikipedia.org/wiki/Mirpur,_Azad_Kashmirhttp://en.wikipedia.org/wiki/Rawalakothttp://en.wikipedia.org/wiki/Muzaffarabadhttp://en.wikipedia.org/wiki/Hari_Singhhttp://en.wikipedia.org/wiki/Maharaja_of_Jammu_and_Kashmir


8/35

Crore business and is confident of meeting its other annual targets as well in its Platinum

Jubilee year.

On May 15 2013, bank announced that it has achieved the target of promised Rs 1000 Crore

profit for the FY 2012-13. The bank posted net profit of Rs 1055.10 crores and business

turnover of Rs 103421 crore for the FY 2012-13. In its Platinum jubilee year, the banks board

of directors recommended special dividend of 500% or Rs 50 per share for 2012-13.

Brief profile

J&K Bank functions as a universal bank in Jammu & Kashmir and as a specialised bank in

the rest of the country. It is also the only private sector bank designated as RBIs agent for

banking business, and carries out the banking business of the Central Government, besides

collecting central taxes for CBDT.

J&K Bank follows a two-legged business model whereby it seeks to increase lending in its

home state which results in higher margins despite modest volumes, and at the same time,

seeks to capture niche lending opportunities on a pan-India basis to build volumes and

improve margins.

J&K Bank operates on the principle of 'socially empowering banking' and seeks to deliver

innovative financial solutions for household, small and medium enterprises.

The Bank, incorporated in 1938, and is listed on the NSE and the BSE. It has a track record

of uninterrupted profits and dividends for four decades. The J&K Bank is rated P1+,

indicating the highest degree of safety by Standard & Poor and CRISIL.

Vision

To catalyse economic transformation and capitalise on growth.

The Banks vision is to engender and catalyse economic transformation of Jammu and

Kashmir and capitalise from the growth induced financial prosperity thus engineered.The

Bank aspires to make Jammu and Kashmir the most prosperous state in the country, by

helping create a new financial architecture for the J&K economy, at the center of which will

be the J&K Bank.

Mission


9/35

The Banks mission lays down a two-fold path: To provide the people of J&K international

quality financial service and solutions and to be a super-specialist bank in the rest of the

country. The two together will make the bank most profitable Bank in the country.

Network

The Bank's Corporate Headquarter is situated in Srinagar. The Bank has a network of 689

business units (branches) and 613 ATMs across the country as on May 15, 2013. During the

year 2012-13, the bank has opened 70 new units thereby increasing its network to 685 while

105 ATMs were commissioned, taking their number to 613.

Awards and recognitions

2011

Business Today - KPMG Study

The Bank was ranked one of the best banks in the Best Bank Study 2011 done byBusiness Today and global Consulting firm KPMG (BT-KPMG). The study ranked the

Bank No. 1 on the basis of NPA coverage ratio which stood best in the industry as at the

end of March 2011.

The Bank was ranked 15th in large banks category in the country based on the last year'sgrowth, quality of assets, productivity and efficiency parameters, leaving state bank of

India, federal bank, HSBC Bank, Standard Chartered bank and other major banks far

behind.

FE India's best banks Award

The Bank won the prestigious Financial Express Best Banks Award in the Old Private Sector

Banks Category for Scaling up its business and strengthening the balance sheet for the yearended March 2011. The Award is the recognition of the Bank's innovative approach towards

the business, both within and outside J&K.

Dun & Bradstreet Banking Awards

J&K Bank was awarded the Best Bank in the prestigious 'Dun & Bradstreet (D&B) - Polaris

software Banking Awards 2011 in the category for "Rural Reach - Private Sector".

2012

Business Today - KPMG Study


10/35

The bank was ranked one of the best banks in the Best Bank Study 2012 done byBusiness Today and KPMG. The Study ranked the Bank No. 1 on the basis of NPA

coverage ratio and the bank was also ranked No. 1 in terms of Cost to income ratio which

stood best in the industry at the end of the March 2012.

The Bank was ranked 4th in Mid sized banks category in the country based on theprevious year's growth, quality of assets, quality of earnings, productivity and efficeincy

and capital adequacy parameters.

2013

FE Indias Best Banks Award-2012-13

The Bank was ranked as No. 1 in Best Old Private Sector Bank category in the survey

conducted across the banking industry. In terms of Profitability, the Bank stands 3rd in the

overall banking industry while as 1ST in the category of Old private sector banks.

The Award is the recognition of the Bank's strong fundamentals and dynamic growth model.


11/35

STATE BANK OF INDIA(SBI)

State Bank of India(SBI) is a multinationalbanking andfinancial services company based

in India. It is agovernment-owned corporation with its headquarters inMumbai,

Maharashtra. As of December 2012, it had assets of US$501 billion and 15,003 branches,

including 157 foreign offices, making it the largest banking and financial services company

in India by assets.

The bank traces its ancestry to British India, through the Imperial Bank of India, to the

founding in 1806 of theBank of Calcutta,making it the oldest commercial bank in theIndian

Subcontinent. Bank of Madras merged into the other two presidency banksBank of

Calcutta and Bank of Bombayto form the Imperial Bank of India, which in turn became the

State Bank of India.Government of India nationalised the Imperial Bank of India in 1955,

withReserve Bank of India taking a 60% stake, and renamed it the State Bank of India. In

2008, the government took over the stake held by the Reserve Bank of India. SBI was ranked

285th in the Fortune Global 500 rankings of the world's biggest corporations for the year

2012.

SBI provides a range of banking products through its network of branches in India and

overseas, including products aimed atnon-resident Indians(NRIs). SBI has 14 regional hubs

and 57 Zonal Offices that are located at important cities throughout the country.

SBI is a regional banking behemoth and has 20% market share in deposits and loans among

Indian commercial banks.

The State Bank of India was named the 29th most reputed company in the world according

toForbes2009 rankings and was the only bank featured in the "top 10 brands of India" list in

an annual survey conducted byBrand Finance and The Economic Timesin 2010.

International presence

As of 28 June 2013, the bank had 180 overseas offices spread over 34 countries. It has

branches of the parent inMoscow,Colombo,Dhaka, Frankfurt, Hong

Kong,Tehran,Johannesburg, London, Los Angeles, Male in theMaldives,Muscat, Dubai,

New York,Osaka, Sydney, and Tokyo. It hasoffshore banking units in theBahamas,

Bahrain, andSingapore, and representative offices inBhutan andCape Town. It also has an

ADB in Boston, USA.
http://en.wikipedia.org/wiki/Bankhttp://en.wikipedia.org/wiki/Financial_servicehttp://en.wikipedia.org/wiki/Government-owned_corporationhttp://en.wikipedia.org/wiki/Mumbai,_Maharashtrahttp://en.wikipedia.org/wiki/Mumbai,_Maharashtrahttp://en.wikipedia.org/wiki/British_Rajhttp://en.wikipedia.org/wiki/Imperial_Bank_of_Indiahttp://en.wikipedia.org/wiki/Bank_of_Calcuttahttp://en.wikipedia.org/wiki/Indian_Subcontinenthttp://en.wikipedia.org/wiki/Indian_Subcontinenthttp://en.wikipedia.org/wiki/Government_of_Indiahttp://en.wikipedia.org/wiki/Reserve_Bank_of_Indiahttp://en.wikipedia.org/wiki/Fortune_Global_500http://en.wikipedia.org/wiki/Non-resident_Indianhttp://en.wikipedia.org/wiki/Forbeshttp://en.wikipedia.org/wiki/Forbeshttp://en.wikipedia.org/wiki/Forbeshttp://en.wikipedia.org/wiki/Brand_Financehttp://en.wikipedia.org/wiki/Moscowhttp://en.wikipedia.org/wiki/Colombohttp://en.wikipedia.org/wiki/Dhakahttp://en.wikipedia.org/wiki/Tehranhttp://en.wikipedia.org/wiki/Johannesburghttp://en.wikipedia.org/wiki/Maldiveshttp://en.wikipedia.org/wiki/Muscat,_Omanhttp://en.wikipedia.org/wiki/Osakahttp://en.wikipedia.org/wiki/Offshore_bankhttp://en.wikipedia.org/wiki/Bahamashttp://en.wikipedia.org/wiki/Singaporehttp://en.wikipedia.org/wiki/Bhutanhttp://en.wikipedia.org/wiki/Cape_Townhttp://en.wikipedia.org/wiki/Cape_Townhttp://en.wikipedia.org/wiki/Bhutanhttp://en.wikipedia.org/wiki/Singaporehttp://en.wikipedia.org/wiki/Bahamashttp://en.wikipedia.org/wiki/Offshore_bankhttp://en.wikipedia.org/wiki/Osakahttp://en.wikipedia.org/wiki/Muscat,_Omanhttp://en.wikipedia.org/wiki/Maldiveshttp://en.wikipedia.org/wiki/Johannesburghttp://en.wikipedia.org/wiki/Tehranhttp://en.wikipedia.org/wiki/Dhakahttp://en.wikipedia.org/wiki/Colombohttp://en.wikipedia.org/wiki/Moscowhttp://en.wikipedia.org/wiki/Brand_Financehttp://en.wikipedia.org/wiki/Forbeshttp://en.wikipedia.org/wiki/Non-resident_Indianhttp://en.wikipedia.org/wiki/Fortune_Global_500http://en.wikipedia.org/wiki/Reserve_Bank_of_Indiahttp://en.wikipedia.org/wiki/Government_of_Indiahttp://en.wikipedia.org/wiki/Indian_Subcontinenthttp://en.wikipedia.org/wiki/Indian_Subcontinenthttp://en.wikipedia.org/wiki/Bank_of_Calcuttahttp://en.wikipedia.org/wiki/Imperial_Bank_of_Indiahttp://en.wikipedia.org/wiki/British_Rajhttp://en.wikipedia.org/wiki/Mumbai,_Maharashtrahttp://en.wikipedia.org/wiki/Mumbai,_Maharashtrahttp://en.wikipedia.org/wiki/Government-owned_corporationhttp://en.wikipedia.org/wiki/Financial_servicehttp://en.wikipedia.org/wiki/Bank


12/35

The Canadian subsidiary, State Bank of India (Canada) also dates to 1982. It has seven

branches, four in theToronto area and three in theVancouver area.

SBI operates several foreign subsidiaries or affiliates. In 1990, it established an offshore

bank: State Bank of India (Mauritius).

In 1982, the bank established a subsidiary, State Bank of India (California), which now has

ten branchesnine branches in the state of California and one in Washington, D.C. The 10th

branch was opened in Fremont, California on 28 March 2011. The other eight branches in

California are located in Los Angeles, Artesia, San Jose, Canoga Park, Fresno, San Diego,

Tustin and Bakersfield.

InNigeria, SBI operates as INMB Bank. This bank began in 1981 as the Indo-Nigerian

Merchant Bank and received permission in 2002 to commence retail banking. It now has five

branches in Nigeria.

InNepal,SBI owns 55% of Nepal SBI Bank, which has branches throughout the country. In

Moscow, SBI owns 60% ofCommercial Bank of India, withCanara Bank owning the rest.

InIndonesia,it owns 76% of PT Bank Indo Monex.

The State Bank of India already has a branch in Shanghai and plans to open one in Tianjin.

InKenya, State Bank of India owns 76% of Giro Commercial Bank, which it acquired

for US$8 million in October 2005.

Associate banks

SBI has five associate banks; all use the State Bank of India logo, which is a blue circle, and

all use the "State Bank of" name, followed by the regional headquarters' name:

State Bank of Bikaner & Jaipur State Bank of Hyderabad State Bank of Mysore State Bank of Patiala State Bank of TravancoreOther SBI service points

SBI has 27,000+ATMs (25,000th ATM was inaugurated by the then Chairman of State Bank

Shri O.P. Bhatt on 31 March 2011, the day of his retirement); and SBI group (including

associate banks) has about 45,000 ATMs. SBI has become the first bank to install an ATM at
http://en.wikipedia.org/wiki/Torontohttp://en.wikipedia.org/wiki/Vancouverhttp://en.wikipedia.org/wiki/Nigeriahttp://en.wikipedia.org/wiki/Nepalhttp://en.wikipedia.org/wiki/Commercial_Bank_of_Indiahttp://en.wikipedia.org/wiki/Canara_Bankhttp://en.wikipedia.org/wiki/Indonesiahttp://en.wikipedia.org/wiki/Tianjinhttp://en.wikipedia.org/wiki/Kenyahttp://en.wikipedia.org/wiki/Giro_Commercial_Bankhttp://en.wikipedia.org/wiki/State_Bank_of_Bikaner_%26_Jaipurhttp://en.wikipedia.org/wiki/State_Bank_of_Hyderabadhttp://en.wikipedia.org/wiki/State_Bank_of_Mysorehttp://en.wikipedia.org/wiki/State_Bank_of_Patialahttp://en.wikipedia.org/wiki/State_Bank_of_Travancorehttp://en.wikipedia.org/wiki/Automated_teller_machinehttp://en.wikipedia.org/wiki/Automated_teller_machinehttp://en.wikipedia.org/wiki/State_Bank_of_Travancorehttp://en.wikipedia.org/wiki/State_Bank_of_Patialahttp://en.wikipedia.org/wiki/State_Bank_of_Mysorehttp://en.wikipedia.org/wiki/State_Bank_of_Hyderabadhttp://en.wikipedia.org/wiki/State_Bank_of_Bikaner_%26_Jaipurhttp://en.wikipedia.org/wiki/Giro_Commercial_Bankhttp://en.wikipedia.org/wiki/Kenyahttp://en.wikipedia.org/wiki/Tianjinhttp://en.wikipedia.org/wiki/Indonesiahttp://en.wikipedia.org/wiki/Canara_Bankhttp://en.wikipedia.org/wiki/Commercial_Bank_of_Indiahttp://en.wikipedia.org/wiki/Nepalhttp://en.wikipedia.org/wiki/Nigeriahttp://en.wikipedia.org/wiki/Vancouverhttp://en.wikipedia.org/wiki/Toronto


13/35

Drass in the Jammu & Kashmir Kargil region. This was the Bank's 27,032nd ATM on 27

July 2012.

Logo and slogan

The logo of the State Bank of India is a blue circle with a small cut in the bottom thatdepicts perfection and the small man the common man - being the center of the bank's

business.

Slogans: "PURE BANKING, NOTHING ELSE", "WITH YOU - ALL THE WAY", "ABANK OF THE COMMON MAN", "THE BANKER TO EVERY INDIAN", "THE

NATION BANKS ON US".

Recent awards and recognitions

Best Online Banking Award, Best Customer Initiative Award & Best Risk ManagementAward (Runner Up) by IBA Banking Technology Awards 2010

The Bank of the year 2009, India (won the second year in a row) by The BankerMagazine

Best Bank Large and Most Socially Responsible Bank by the Business Bank Awards2009

Best Bank 2009 by Business India The Most Trusted Brand 2009 by The Economic Times Most Preferred Bank & Most preferred Home loan provider by CNBC Visionaries of Financial Inclusion By FINO Technology Bank of the Year by IBA Banking Technology Awards SKOCH Award 2010 for Virtual corporation Category for its e-payment solution The Brand Trust Report:11th most trusted brand in Hindustan.
http://en.wikipedia.org/wiki/The_Brand_Trust_Reporthttp://en.wikipedia.org/wiki/The_Brand_Trust_Report


14/35

PHARMACEUTICAL INDUSTRY

The Pharmaceutical industry in India is the world's third-largest in terms of volume and

stands 14th in terms of value. According to Department of Pharmaceuticals, Ministry ofChemicals and Fertilizers, the total turnover of India's pharmaceuticals industry between

2008 and September 2009 was US$21.04 billion. While the domestic market was worth

US$12.26 billion. Sale of all types of medicines in the country is expected to reach around

US$19.22 billion by 2012.

Exports of pharmaceuticals products from India increased from US$6.23 billion in 2006-07

to US$8.7 billion in 2008-09 a combined annual growth rate of 21.25%. According to

PricewaterhouseCoopers (PWC) in 2010, India joined among the league of top 10 global

pharmaceuticals markets in terms of sales by 2020 with value reaching US$50 billion.[3]

Some of the major pharmaceutical firms including Sun Pharmaceutical, Cadila Healthcare

andPiramal Healthcare.

Thegovernment started to encourage the growth of drug manufacturing by Indian companies

in the early 1960s, and with the Patents Act in 1970. However, economic liberalization in 90s

by the former Prime Minister P.V. Narasimha Rao and the then Finance Minister, Dr.Manmohan Singh enabled the industry to become what it is today. This patent act removed

composition patents from food and drugs, and though it kept process patents, these were

shortened to a period of five to seven years.

The lack of patent protection made the Indian market undesirable to the multinational

companies that had dominated the market, and while they streamed out. Indian companies

carved a niche in both the Indian and world markets with their expertise in reverse-

engineering new processes for manufacturing drugs at low costs. Although some of the larger

companies have taken baby steps towards drug innovation, the industry as a whole has been

following this business model until the present.

India's biopharmaceutical industry clocked a 17 percent growth with revenues of Rs.137

billion ($3 billion) in the 2009-10 financial year over the previous fiscal. Bio-pharma was the

biggest contributor generating 60 percent of the industry's growth at Rs.8,829 crore, followed

by bio-services at Rs.2,639 crore and bio-agri at Rs.1,936 crore.
http://en.wikipedia.org/wiki/Pharmaceutical_industryhttp://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/wiki/Ministry_of_Chemicals_and_Fertilizers_%28India%29http://en.wikipedia.org/wiki/Ministry_of_Chemicals_and_Fertilizers_%28India%29http://en.wikipedia.org/wiki/PricewaterhouseCoopershttp://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-pwc-3http://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-pwc-3http://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-pwc-3http://en.wikipedia.org/wiki/Sun_Pharmaceuticalhttp://en.wikipedia.org/wiki/Cadila_Healthcarehttp://en.wikipedia.org/wiki/Piramal_Healthcarehttp://en.wikipedia.org/wiki/Government_of_Indiahttp://en.wikipedia.org/wiki/P.V._Narasimha_Raohttp://en.wikipedia.org/wiki/Financehttp://en.wikipedia.org/wiki/Minister_%28government%29http://en.wikipedia.org/wiki/Dr._Manmohan_Singhhttp://en.wikipedia.org/wiki/Dr._Manmohan_Singhhttp://en.wikipedia.org/wiki/Patenthttp://en.wikipedia.org/wiki/Biopharmaceuticalhttp://en.wikipedia.org/wiki/Biopharmaceuticalhttp://en.wikipedia.org/wiki/Patenthttp://en.wikipedia.org/wiki/Dr._Manmohan_Singhhttp://en.wikipedia.org/wiki/Dr._Manmohan_Singhhttp://en.wikipedia.org/wiki/Minister_%28government%29http://en.wikipedia.org/wiki/Financehttp://en.wikipedia.org/wiki/P.V._Narasimha_Raohttp://en.wikipedia.org/wiki/Government_of_Indiahttp://en.wikipedia.org/wiki/Piramal_Healthcarehttp://en.wikipedia.org/wiki/Cadila_Healthcarehttp://en.wikipedia.org/wiki/Sun_Pharmaceuticalhttp://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-pwc-3http://en.wikipedia.org/wiki/PricewaterhouseCoopershttp://en.wikipedia.org/wiki/Ministry_of_Chemicals_and_Fertilizers_%28India%29http://en.wikipedia.org/wiki/Ministry_of_Chemicals_and_Fertilizers_%28India%29http://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/wiki/Pharmaceutical_industry


15/35

The number of purely Indian pharma companies is fairly low. Indian pharma industry is

mainly operated as well as controlled by dominant foreign companies having subsidiaries in

India due to availability of cheap labour in India at lowest cost. In 2002, over 20,000

registered drug manufacturers in India sold $9 billion worth of formulations and bulk drugs.

85% of these formulations were sold in India while over 60% of the bulk drugs were

exported, mostly to the United States and Russia. Most of the players in the market are small-

to-medium enterprises; 250 of the largest companies control 70% of the Indian market .[8]

Thanks to the 1970 Patent Act, multinationals represent only 35% of the market, down from

70% thirty years ago.

Most pharma companies operating in India, even the multinationals, employ Indians almost

exclusively from the lowest ranks to high level management. Mirroring the social structure,

firms are very hierarchical. Homegrown pharmaceuticals, like many other businesses in

India, are often a mix of public and private enterprise. Although many of these companies are

publicly owned, leadership passes from father to son and the founding family holds a

majority share.

In terms of the global market, India currently holds a modest 1-2% share, but it has been

growing at approximately 10% per year. India gained its foothold on the global scene with its

innovatively engineered generic drugs and active pharmaceutical ingredients (API), and it is

now seeking to become a major player in outsourced clinical research as well as contract

manufacturing and research. There are 74 U.S. FDA-approved manufacturing facilities in

India, more than in any other country outside the U.S, and in 2005, almost 20% of all

Abbreviated New Drug Applications (ANDA) to the FDA are expected to be filed by Indian

companies. Growth in other fields notwithstanding, generics are still a large part of the

picture. London research company Global Insight estimates that Indias share of the global

generics market will have risen from 4% to 33% by 2007. The Indian pharmaceutical

industry has become the third largest producer in the world and is poised to grow into an

industry of $ 20 billion in 2015 from the current turnover of $ 12 billion.
http://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-8http://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-8http://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-8http://en.wikipedia.org/wiki/Pharmaceutical_industry_in_India#cite_note-8


16/35

PFIZER

Pfizer Limited (PL) is one of the fastest growing pharmaceutical companies in India with

a consistent higher than market's growth rate, it came to the Indian market in 21stNovember of the year 1950 through a company named Dumex Limited. The first

production facility was set up at Darukhanna in Mumbai, where products like Protinex

and Isonex (isoniazid - an anti -TB drug) were manufactured. Subsequently, this plant

also produced Becosules and Corex, both of which remain mega products till date. PL's

medicines library includes about 3 million compounds and the pipeline holds

approximately 169 new molecular entities and 73 enhancement programs for marketed

products in development and about 400 compounds in discovery research across multiple

therapeutic areas, which all covers pharmaceutical, animal health and services. In 1960,

Pfizer established a large and modern plant at Thane, near Mumbai, which housed

manufacturing, quality control and product research facilities. This plant won a number

of national safety awards. In November of the year 1965, the Company had entered into a

licence agreement with Pfizer Corporation continuing the royalty-free licence granted to

it for the use of Pfizer processes, technical know-how, etc., relating to the manufacture of

existing products in the pharmaceutical, veterinary and agricultural fields and giving the

Company the right to obtain from Pfizer Corporation by Mutual agreement, technical

know-how and other assistance relating to the manufacture of new items. A large

research and development laboratory of the company at Thane was commissioned in the

year 1969. As of 4th March of the year 1977, the company's status was changed as a

public limited company. Piroxicam, a major anti-artharitic drug, was launched in India in

the last quarter of the year 1989 under the brand name of DOLONEX. The former

subsidiary Dumex Ltd was amalgamated with the company effect from 1st April of the

year 1992 and also during the same year, the pharmaceuticals division introduced

Dolmex' intramuscular injection. Development Operations (Dev Ops) India, formerly a

part of the Clinical Research Division, was established in 1995. The operations started

with the hiring of a statistician in 1995. Pfizer had acquired the animal healthcare

operations of SmithKline Beecham in the year 1996. The pace of work of Clinical

Research Division was picked up in 1998 and this was followed by a substantial growth

in terms of activities and resources, especially in data management. A dedicated

Informatics group of the company for all technical and applications support has been


17/35

available since 1997. The Company closed down its manufacturing plant at Ankleshwar

with effect from 31st July of the year 1999. During the year 2000, PL made tie-up with

Shantha Biotechnics for parallel marketing of its products. Express Pharma Biz Award

came to company's hands in the year 2002 for overall performance. The operational

merger between the company and Parke-Davis had been completed in the year 2002. A

year after, in 2003, Pfizer had initiated the global implementation of 'Clinicopia Labelling

and Clinicopia Supply Chain' a part of inferno's Clinical Trails management suite. In mid

2003, the Mumbai group was aligned under Dev Ops Europe to emphasize its focus on

operations and facilitate more interactions and project engagements from all sites. In the

year 2004, PL had entered into an agreement with Sanofi Synthelabo (India) Ltd for co-

promotion of its product, Daxid. The Company's seven key brands (Corex, Becosules,

Magnex, Dolonex, Gelusil, Minipress XL and Benadryl) had listed among the Top-100

Industry brands, in the year 2005. Viagra was the first global brand launched successfully

in December of the year 2005, followed by Caduet (a combination of atorvastatin and

amlodipine for treatment of patients with dyslipidemia and hypertension) and LYRICA

(pregabalin, for treatment of neuropathic pain), both of which launched in the first quarter

of 2006. The Company bagged Pharma Excellence Awards 2006 in 'Innovative Products

of the Year' category for Exubera. The global divesture of the OTC business to Johnson

& Johnson in December 2006 and Pfizer, won a US Supreme Court appeal in April of the

year 2007 that aimed to open the company's Lipitor cholesterol pill, the most widely

prescribed drug in the world, to generic competition, also in end of the year 2007, the

company had transferred its exclusive license to Johnson & Johnson for a total

consideration of Rs 2,148.51 million. Pfizer had launched Champix, a non-nicotine

smoking cessation prescription drug during February of the year 2008.

Pursuing Innovation

The pursuit of innovation is basic to Pfizer's culture. It shapes our strategy, defines our

purpose, and governs every facet of our operations -- from research and development (R&D)

that leads to pharmaceutical inventions, to the transfer of knowledge to patients and

providers, to the way we respond to the changing marketplace.

Pfizer scientists have produced innovative breakthroughs in a wide range of research areas,


18/35

including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension,

bacterial infections and systemic fungal infections. And today we're taking on some of the

world's most difficult diseases, including cancer, arthritis, and osteoporosis.

Pfizer in India

Pfizer Limited (India) has a turnover of US$ 184.96 million (March 2012) One of the highest spenders in pharmaceutical R&D globally, Pfizer has made clinical

research investments of US$ 1.18 million (March 2012) in India

The company was awarded the FICCI SEDF (Socio Economic Development Foundation)Certificate of Commendation for its social responsibility efforts

Pfizer has won several awards including that for the multinational pharmaceutical companyof the year and the most respected MNC

About our products

Six Pfizer brands feature among the Top 100 pharmaceutical brands in India Two of Pfizer India's brands -- Corex (Cough Formulation) and Becosules (Multivitamin) --

continue to rank among the Top 15 pharmaceutical drug brands

Pfizer has won the Golden Peacock Innovative Product for Magnex (Sulperazon) Becosules has won the Most Trusted Brand Award

Going beyond medicines

In India, Pfizer instituted the first ever Disease Management Programme -- Healthy Heartin Cardio Vascular Disease (Hypertension, Chronic Stable Angina and Dyslipidemia), in

partnership with Apollo Hospital, Hyderabad and Apollo Hospital, Chennai

We offer Patient Assistance Programmes for Glaucoma, Breast Cancer and Neuropathic Pain We partner with physician associations to develop recommendations / guidelines of

managing specific diseases


19/35

SANOFI INDIA LTD

HISTORY

Sanofi has a rich history of innovation dating back over 100 years.

Sanofi was formed in 2004 when Sanofi-Synthlabo (created from 1999 merger of Sanofi and

Synthlabo) acquired Aventis (the result of the 1999 merger of Hoechst and Rhne-Poulenc).

Sanofi was founded in 1973 by the French oil company Elf Aquitaine, when it acquired the

pharmaceutical group Labaz. Sanofi expanded through a combination of international

acquisitions and internal product development epitomized by the launch of its first major

product, Ticlid. Sanofi entered the American market in 1994 with the acquisition of Sterling

Winthrop. Innovation remained centre stage and in 1986 the prestigious Prix Galien was

awarded for Sanofis work on the anti-coagulant heparin and in 1987 for the anti-platelet drug

Ticlid.

Synthlabo was formed in 1970 with the merger of two French pharmaceutical laboratories,

the Laboratoires Dausse (founded in 1834) and the Laboratoires Robert & Carrire (founded

in 1899).

Aventis was created in 1999, via the merger of the French company Rhne Poulenc and

Hoechst Marion Roussel. Hoechsts history mirrors the expansion of the chemicals industry.

Hoechst strengthened its existing drug-development engagement with the 1974 acquisition of

Roussel-Uclaf, followed by its merger with the American pharmaceutical company Marion

Merrell in 1995. As a result, Aventis had global reach and a strong foundation in innovative

life science technologies. The company was one of the first to invest in the emerging new

wave technologies of genomics, immunology and gene therapy.

Rhne-Poulenc was created in 1928 when it was active in chemicals, textiles andpharmaceuticals. In the 1990s the company acquired the American pharmaceutical company

Rorer (in two steps, 1990 and 1997), the vaccine laboratory Pasteur Mrieux Connaught

(1994) and the British pharmaceuticals company Fisons (1995) to become an important

global player in pharmaceuticals.

Since 2004, Sanofi has developed as a diversified global healthcare company using

innovation to meet the needs of patients throughout the world.


20/35

Today, the core strengths of Sanofi comprise a worldwide presence, market leadership in

vaccines with sanofi pasteur, major biological products and a strong and long-established

presence in emerging markets. Company business activities also include consumer healthcare

products, generics and animal health products.

Aventis Pharma Ltd is a pharmaceutical company that discovers, develops and markets

branded prescription drugs and vaccines to protect and improve the quality of life of people

around the world. The company provides medicines for the treatment of patients in several

therapeutic areas such as Cardiovascular Disease, Thrombotic Diseases, Metabolic Disorders,

Oncology, Disorders of the Central Nervous System, Internal medicine and Vaccines. They

are having their manufacturing facilities at Ankleshwar in Gujarat and Verna in Goa. The

company also manufactures their products on loan license which are manufactured in

accordance with the same quality standards as those prevalent at their manufacturing sites.

Aventis Pharma Ltd was incorporated in May 1956 under the name Hoechst Fedco Pharma

Pvt Ltd. Over the years, the name was changed to Hoechst Pharmaceuticals Pvt Ltd, Hoechst

India Ltd and Hoechst Marion Roussel Ltd. Sanofi-aventis, one of the world's leading

pharmaceutical companies, and their 100% subsidiary, Hoechst GmbH, are the major

shareholders of Aventis Pharma Ltd and together hold 50.12% of their paid-up share capital.

During the year 1997-98, the joint venture company Chiron Behring Vaccines Pvt Ltd started

to manufacture anti-rabbies vaccine 'Rabipur'. Roussel India Ltd was amalgameted with the

company with effect from April 1 1997 and Hoechst Nepal (Pvt) Ltd, a subsidiary company

in Nepal has been wound up during the year. During the year 1999-2000, Aventis has

launched anti-diabetic Amaryl broad spectrum anti-infective Tavanic and line extension of

anti-hypertensive Cardace H. In the year 2001, Rhone-Poulenc Rorer (India) Pvt Ltd was

amalgamated with the company. The company name was changed from Hoechst Marion

Roussel Ltd to Aventis Pharma Ltd with effect from July 11 2001. In July 2003. the company

launched Lantus, the world's first and only once a day insulin and in December 2003,

Actonel, designed for the treatment of osteoporosis was launched. In the year 2004, the

company came under the control of Sanofi-Synthelabo, now called sanofi-aventis which

acquired indirect control 50.1% of the company's paid-up share capital. In the year 2006, the

company completed the project for setting up additional facilities for manufacturing

Combiflam Tablets in Ankleshwar, Gujarat. In the year 2007, the company launched Cardace

H 10 mg as a comprehensive cardiovascular treatment option in hypertension at risk patients.

In May 2007, the company launched a line extension, Amaryl M. A new granulation train


21/35

dedicated for production of Combiflam tablets was installed in Ankleshwar. This product

which was being manufactured partly in a toll manufacturing site is now planned to be

manufactured entirely in Ankleshwar. The company brands namely Combiflam, Cardace,

Rabipur, Amaryl, Avil and AllegraTM feature in the top 100 brands of the retail market. In

that, Cardace continues to be the number one cardiovascular brand in the Indian

pharmaceutical market. The company plans to upgrade the capacities in Ankleshwar for the

manufacture of Combiflam. Also, the Ankleshwar API plant will commence manufacture of

Pentoxifylline which was so far imported and is the raw material for manufacture of Trental.

The product will also be exported to Hungary. In April 2008, the company has launched a

new prefilled diaposable insulin pen, SoloStar for use with the 24-hour insulin Lantus. This

disposable insulin pen is to be used for the treatment of hyperglycemia in people with type 1

or type 2 diabetes.


22/35

INFORMATION TECHNOLOGY

Information Technology (IT) industry in India is one of the fastest growing industries. Indian

IT industry has built up valuable brand equity for itself in the global markets. IT industry in

India comprises of software industry and information technology enabled services (ITES),

which also includes business process outsourcing (BPO) industry. India is considered as a

pioneer in software development and a favorite destination for IT-enabled services.

The origin of IT industry in India can be traced to 1974, when the mainframe manufacturer,

Burroughs, asked its India sales agent, Tata Consultancy Services (TCS), to export

programmers for installing system software for a U.S. client. The IT industry originated

under unfavorable conditions. Local markets were absent and government policy toward

private enterprise was hostile. The industry was begun by Bombay-based conglomerates

which entered the business by supplying programmers to global IT firms locatedoverseas.

During that time Indian economy was state-controlled and the state remained hostile to the

software industry through the 1970s. Import tariffs were high (135% on hardware and 100%

on software) and software was not considered an "industry", so that exporters were ineligible

for bank finance. Government policy towards IT sector changed when Rajiv Gandhi becamePrime Minister in 1984. His New Computer Policy (NCP-1984) consisted of a package of

reduced import tariffs on hardware and software (reduced to 60%), recognition of software

exports as a "delicensed industry", i.e., henceforth eligible for bank finance and freed from

license-permit raj, permission for foreign firms to set up wholly-owned, export-dedicated

units and a project to set up a chain of software parks that would offer infrastructure at

below-market costs. These policies laid the foundation for the development of a world-class

IT industry in India.

Today, Indian IT companies such as Tata Consultancy Services (TCS), Wipro, Infosys, HCL

et al are renowned in the global market for their IT prowess. Some of the major factors which

played a key role in India's emergence as key global IT player are:


23/35

Indian Education System

The Indian education system places strong emphasis on mathematics and science, resulting in

a large number of science and engineering graduates. Mastery over quantitative concepts

coupled with English proficiency has resulted in a skill set that has enabled India to reap the

benefits of the current international demand for IT.

High Quality Human Resource

Indian programmers are known for their strong technical and analytical skills and their

willingness to accommodate clients. India also has one of the largest pools of English-

speaking professionals.

Competitive Costs

The cost of software development and other services in India is very competitive as compared

to the West.

Infrastructure Scenario

Indian IT industry has also gained immensely from the availability of a robust infrastructure

(telecom, power and roads) in the country

.

In the last few years Indian IT industry has seen tremendous growth. Destinations such as

Bangalore, Hyderabad and Gurgaon have evolved into global IT hubs. Several IT parks have


24/35

come up at Bangalore, Hyderabad, Chennai, Pune, Gurgaon etc. These parks offer Silicon

Valley type infrastructure. In the light of all the factors that have added to the strength of

Indian IT industry, it seems that Indian success story is all set to continue.


25/35

INFOSYS

Infosys Limited(formerly Infosys Technologies Limited) is an Indianmultinationalprovider

ofbusiness consulting,information technology,software

engineering andoutsourcing services. It is headquartered inBangalore, Karnataka Infosys isthe third-largest India-based IT services companyby 2012 revenues, and the second largest

employer ofH-1B visaprofessionals in the United States, as of 2012. On 28 March 2013,

itsmarket capitalisation was $30.8 billion, making it India's sixth largest publicly traded

company.

History

Infosys was co-founded in 1981 byNarayan Murthy,Nandan Nilekani,N. S. Raghavan,S.

Gopalakrishnan,S. D. Shibulal,K. Dinesh and Ashok Arora after they resigned fromPatniComputer Systems.The company was incorporated as "Infosys Consultants Pvt Ltd." with a

capital of $250 in Model Colony, Pune as the registered office and signed up its first client,

Data Basics Corporation, in New York. In 1983, Infosys corporate headquarters was

relocated to Bangalore. It changed its name to "Infosys Technologies Private Limited" in

April 1992. It changed its name to "Infosys Technologies Limited" when it became a public

limited company in June 1992. It was renamed to "Infosys Limited" in June 2011.

In 1999, Infosys achievedCapability Maturity Model level 5 certification.

On 1 June 2013, Mr. Narayana Murthy, one of the founding members of Infosys and its long

time CEO, returned back from his retirement to assume office in Infosys as its Executive

Chairman. His return was on Board's request to bring the company back on track. Infosys has

been consistently ranked by Glassdoor.com and other worldwide Researchers and former

employees as the "worst" place to work. Employees often complain of the rigid and

unexplained policies, disappointingly low salaries, and working overtime. Currently, Infosys

is the employer with the highest attrition rate of 67%. Besides, it was discovered in

independent surveys that new employees generally quit the company after working for an

average of one year and five months.

Locations

Infosys has 87 global software development centers of which 32 are in India and 55 are

outside India. It has 69 sales offices around the world of which 2 are in India and 67 are

outside India.In recent years, Infosys has begun shifting operations to theUnited States and other countries

outside of India. In 2012, Infosys announced a new office in Milwaukee, Wisconsin to

serviceHarley-Davidson, being the 18th international office in the United States. Infosys

hired 1,200 United States employees in 2011, and expanded the workforce by an additional

2,000 employees in 2012.[21]Globally, Infosys has 67 offices between

theUS,India,China,Australia,Japan,Middle East,United

Kingdom,Germany,France,Switzerland,Netherlands,Poland,Canada.

Initiatives
http://en.wikipedia.org/wiki/Multinational_corporationhttp://en.wikipedia.org/wiki/Business_consultinghttp://en.wikipedia.org/wiki/Information_technologyhttp://en.wikipedia.org/wiki/Software_engineeringhttp://en.wikipedia.org/wiki/Software_engineeringhttp://en.wikipedia.org/wiki/Outsourcinghttp://en.wikipedia.org/wiki/Bangalore,_Karnatakahttp://en.wikipedia.org/wiki/Top_software_companies_in_Indiahttp://en.wikipedia.org/wiki/H-1B_visahttp://en.wikipedia.org/wiki/Market_capitalisationhttp://en.wikipedia.org/wiki/Narayan_Murthyhttp://en.wikipedia.org/wiki/Nandan_Nilekanihttp://en.wikipedia.org/wiki/N._S._Raghavanhttp://en.wikipedia.org/wiki/S._Gopalakrishnanhttp://en.wikipedia.org/wiki/S._Gopalakrishnanhttp://en.wikipedia.org/wiki/S._D._Shibulalhttp://en.wikipedia.org/wiki/Patni_Computer_Systemshttp://en.wikipedia.org/wiki/Patni_Computer_Systemshttp://en.wikipedia.org/wiki/Capability_Maturity_Modelhttp://en.wikipedia.org/wiki/United_Stateshttp://en.wikipedia.org/wiki/Milwaukeehttp://en.wikipedia.org/wiki/Harley-Davidsonhttp://en.wikipedia.org/wiki/Infosys#cite_note-Milwaukee-21http://en.wikipedia.org/wiki/Infosys#cite_note-Milwaukee-21http://en.wikipedia.org/wiki/Infosys#cite_note-Milwaukee-21http://en.wikipedia.org/wiki/UShttp://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/wiki/Chinahttp://en.wikipedia.org/wiki/Australiahttp://en.wikipedia.org/wiki/Japanhttp://en.wikipedia.org/wiki/Middle_Easthttp://en.wikipedia.org/wiki/United_Kingdomhttp://en.wikipedia.org/wiki/United_Kingdomhttp://en.wikipedia.org/wiki/Germanyhttp://en.wikipedia.org/wiki/Francehttp://en.wikipedia.org/wiki/Switzerlandhttp://en.wikipedia.org/wiki/Netherlandshttp://en.wikipedia.org/wiki/Polandhttp://en.wikipedia.org/wiki/Canadahttp://en.wikipedia.org/wiki/Canadahttp://en.wikipedia.org/wiki/Polandhttp://en.wikipedia.org/wiki/Netherlandshttp://en.wikipedia.org/wiki/Switzerlandhttp://en.wikipedia.org/wiki/Francehttp://en.wikipedia.org/wiki/Germanyhttp://en.wikipedia.org/wiki/United_Kingdomhttp://en.wikipedia.org/wiki/United_Kingdomhttp://en.wikipedia.org/wiki/Middle_Easthttp://en.wikipedia.org/wiki/Japanhttp://en.wikipedia.org/wiki/Australiahttp://en.wikipedia.org/wiki/Chinahttp://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/wiki/UShttp://en.wikipedia.org/wiki/Infosys#cite_note-Milwaukee-21http://en.wikipedia.org/wiki/Harley-Davidsonhttp://en.wikipedia.org/wiki/Milwaukeehttp://en.wikipedia.org/wiki/United_Stateshttp://en.wikipedia.org/wiki/Capability_Maturity_Modelhttp://en.wikipedia.org/wiki/Patni_Computer_Systemshttp://en.wikipedia.org/wiki/Patni_Computer_Systemshttp://en.wikipedia.org/wiki/S._D._Shibulalhttp://en.wikipedia.org/wiki/S._Gopalakrishnanhttp://en.wikipedia.org/wiki/S._Gopalakrishnanhttp://en.wikipedia.org/wiki/N._S._Raghavanhttp://en.wikipedia.org/wiki/Nandan_Nilekanihttp://en.wikipedia.org/wiki/Narayan_Murthyhttp://en.wikipedia.org/wiki/Market_capitalisationhttp://en.wikipedia.org/wiki/H-1B_visahttp://en.wikipedia.org/wiki/Top_software_companies_in_Indiahttp://en.wikipedia.org/wiki/Bangalore,_Karnatakahttp://en.wikipedia.org/wiki/Outsourcinghttp://en.wikipedia.org/wiki/Software_engineeringhttp://en.wikipedia.org/wiki/Software_engineeringhttp://en.wikipedia.org/wiki/Information_technologyhttp://en.wikipedia.org/wiki/Business_consultinghttp://en.wikipedia.org/wiki/Multinational_corporation


26/35

Infosys Foundation

In 1996, Infosys established the Infosys Foundation, to support the underprivileged sections

of society. At the outset, the Infosys Foundation implemented programs inKarnataka. It

subsequently coveredTamil Nadu,Andhra Pradesh,Maharashtra,Odisha, andPunjab in a

phased manner. A team at the Foundation identifies programs in the areas of Healthcare,

Education, Culture, Destitute Care and Rural Development.

Academic Entente

Infosys' Global Academic Relations team forges Academic Entente (AcE) with academic

and partner institutions. It explores co-creation opportunities between Infosys and academia

through case studies, student trips and speaking engagements. They also collaborate on

technology, emerging economies, globalization, and research. Some initiatives include

research collaborations, publications, conferences and speaking sessions, campus visits and

campus hiring.

Infosys Labs

Infosys Labs is organized as a global network of research labs and innovation hubs.

Infosys Labs collaborates with leading national and international universities such as

theUniversity of Southern California Viterbi School of Engineering, University of

Cambridge,Queensland University of Technology, University of Illinois at Urbana

Champaign,Indian Institute of Technology Bombay,IITB-Monash Research

Academy,Purdue University,International Institute of Information Technology, Bangalore.

Awards and Recognitions

Infosys was ranked #19 amongst the world's most innovative companies byForbes.

Boston Consulting Group has listed it in the list of top ten technology companies for total

shareholder return. Infosys was in the list of top twenty green companies inNewsweek's

Green Rankings for 2012.

Infosys was voted India's most admired company inThe Wall Street Journal Asia 200every

year since 2000. Its corporate governance practices were recognized by The Asset Platinum

awardand the IR Global Rankings. It was also ranked as the 15th most trusted brand in India

byThe Brand Trust Report.

Infosys Cloud Ecosystem Hub won the 2012 Golden Peacock Award for the most innovative

product/service.
http://en.wikipedia.org/wiki/Karnatakahttp://en.wikipedia.org/wiki/Tamil_Naduhttp://en.wikipedia.org/wiki/Andhra_Pradeshhttp://en.wikipedia.org/wiki/Maharashtrahttp://en.wikipedia.org/wiki/Odishahttp://en.wikipedia.org/wiki/Punjab,_Indiahttp://en.wikipedia.org/wiki/University_of_Southern_California_Viterbi_School_of_Engineeringhttp://en.wikipedia.org/wiki/University_of_Cambridgehttp://en.wikipedia.org/wiki/University_of_Cambridgehttp://en.wikipedia.org/wiki/Queensland_University_of_Technologyhttp://en.wikipedia.org/wiki/University_of_Illinois_at_Urbana_Champaignhttp://en.wikipedia.org/wiki/University_of_Illinois_at_Urbana_Champaignhttp://en.wikipedia.org/wiki/Indian_Institute_of_Technology_Bombayhttp://en.wikipedia.org/wiki/IITB-Monash_Research_Academyhttp://en.wikipedia.org/wiki/IITB-Monash_Research_Academyhttp://en.wikipedia.org/wiki/Purdue_Universityhttp://en.wikipedia.org/wiki/International_Institute_of_Information_Technology,_Bangalorehttp://en.wikipedia.org/wiki/Forbeshttp://en.wikipedia.org/wiki/Boston_Consulting_Grouphttp://en.wikipedia.org/wiki/Newsweekhttp://en.wikipedia.org/wiki/The_Wall_Street_Journalhttp://en.wikipedia.org/wiki/The_Brand_Trust_Reporthttp://en.wikipedia.org/wiki/The_Brand_Trust_Reporthttp://en.wikipedia.org/wiki/The_Wall_Street_Journalhttp://en.wikipedia.org/wiki/Newsweekhttp://en.wikipedia.org/wiki/Boston_Consulting_Grouphttp://en.wikipedia.org/wiki/Forbeshttp://en.wikipedia.org/wiki/International_Institute_of_Information_Technology,_Bangalorehttp://en.wikipedia.org/wiki/Purdue_Universityhttp://en.wikipedia.org/wiki/IITB-Monash_Research_Academyhttp://en.wikipedia.org/wiki/IITB-Monash_Research_Academyhttp://en.wikipedia.org/wiki/Indian_Institute_of_Technology_Bombayhttp://en.wikipedia.org/wiki/University_of_Illinois_at_Urbana_Champaignhttp://en.wikipedia.org/wiki/University_of_Illinois_at_Urbana_Champaignhttp://en.wikipedia.org/wiki/Queensland_University_of_Technologyhttp://en.wikipedia.org/wiki/University_of_Cambridgehttp://en.wikipedia.org/wiki/University_of_Cambridgehttp://en.wikipedia.org/wiki/University_of_Southern_California_Viterbi_School_of_Engineeringhttp://en.wikipedia.org/wiki/Punjab,_Indiahttp://en.wikipedia.org/wiki/Odishahttp://en.wikipedia.org/wiki/Maharashtrahttp://en.wikipedia.org/wiki/Andhra_Pradeshhttp://en.wikipedia.org/wiki/Tamil_Naduhttp://en.wikipedia.org/wiki/Karnataka


27/35

ORACLE FINANCIAL SERVICES SOFTWARE LTD

Oracle Financial Services Software Limited(formerly called i-flex Solutions

LimitedBSE:532466)is a subsidiary ofOracle Corporation.It is an IT solution provider tothe banking industry. It claims to have more than 900 customers in over 145 countries. Oracle

Financial Services Software Limited is ranked No. 9 in IT companies of India and overall

ranked No. 253 inFortune India 500 list in 2011.

Oracle Financial Services Software Limited (erstwhile i-flex solutions) (OFSSL) is a world

leader in providing IT solutions to the financial services industry. The Company was

incorporated in September 27, 1989 as Citicorp Information Technology Industries Ltd. The

Company addressing the entire financial services space through a comprehensive portfolio of

products, IT services, consulting and knowledge process outsourcing services. With the

experience of delivering value-based IT solutions to over 810 financial institutions across 130

countries. OFSSL has 14 development centers across India, Singapore and the USA. The

Company has a strong global reach with a sales, marketing and support presence in 27

overseas locations operating across four subsidiaries (i-flex solutions inc. in the USA, i-flex

solutions b.v. in the Netherlands, i-flex solutions pte. ltd. in Singapore and iPSL in India). In

addition, 30 corporate business partners and 32 implementation partners represent i-flexacross the globe. The Company also has strong alliance and/or implementation relationships

with industry leaders such as Hewlett-Packard, IBM, Sun Microsystems and Intel. CITIL

(Citicorp Information Technology Industries Limited), spun off from COSL (Citicorp

Overseas Software Limited), commences first year of operations in the year 1992. In 1995,

CITIL gains recognition for establishing world-class processes and quality Standards, It

attained SEI CMM Level 4, becomes the first financial software firm in the world and one

out of six companies worldwide to achieved this distinction at that time. CITIL established

the Center of Excellence during the year 1996 for business intelligence to provide specialized

consulting and software products, as well as services in data warehousing and business

intelligence. A complete banking product suite for retail, consumer, corporate, investment

and internet banking, consumer lending, asset management and investor servicing, including

payments (SWIFTNet and SEPA) was launched in the year 1997 under the name of

FLEXCUBE. MicroBanker becomes the 6th international banking product in the world to be

used by 100 customers in 1998 and the FLEXCUBE starts gaining traction and international

leadership. During the year 1999, FLEXCUBE Information Center, a Web-enabled business
http://en.wikipedia.org/wiki/Bombay_Stock_Exchangehttp://www.bseindia.com/bseplus/StockReach/AdvanceStockReach.aspx?scripcode=532466http://en.wikipedia.org/wiki/Oracle_Corporationhttp://en.wikipedia.org/wiki/Fortune_India_500http://en.wikipedia.org/wiki/Fortune_India_500http://en.wikipedia.org/wiki/Oracle_Corporationhttp://www.bseindia.com/bseplus/StockReach/AdvanceStockReach.aspx?scripcode=532466http://en.wikipedia.org/wiki/Bombay_Stock_Exchange


28/35

intelligence system was launched along with a Center of Excellence for CRM and the Java

Center for financial services also established. CITIL was renamed as i-flex solutions limited

in the year 2000. During the same year 2000, Center of Excellence for e-services launched

Separate business unit established to address the Applications Services Provider (ASP)

market. i-fl ex solutions b.v., a 100 percent subsidiary of the company opened in Amsterdam,

The Netherlands. The company's financial software development facilities were established

in the year 2001 at Pune and Chennai and fully owned subsidiaries set up in USA and

Singapore, i-flex solutions b.v. in Amsterdam, The Netherlands, becomes operational, i-fl ex

Consulting was launched. EBZ Online, a software company was joined with the company

during the year 2002 through which i-flex's product, Flexcube, for made available to

cooperative banks. Dotex International, a joint venture company supported by NSE.IT and i-

flex Solutions Ltd, signed a memorandum of understanding (MoU) with BgSE Financials

Ltd, a subsidiary of the Bangalore Stock Exchange, to give Internet trading service to the

members of the exchange. The Company entered into capital market with Initial Public

Offering (IPO) of an issue of 3,961,700 equity shares. I-flex opened its first Overseas

Software Development Center in Singapore in the year 2002. In the year 2003, the company's

flagship product FLEXCUBE ranked the world's No.1 selling Universal Banking Solution

and during the same year 2003, I-flex sets up development centre in New York, Wins a major

order from HypoVereinsbank Group (HVB Group), Germany, Inaugurated FLEXCUBE

Support & Prime Sourcing Solutions Centre in London and acquisition of Super Solutions

Corporation in all cash deal of .5 million was made. Waters Magazine ranked Mantas as the

Best Anti-Money Laundering Solution and Best Compliance Solution for 2003. Waters

Magazine ranked Mantas as the Best Anti-Money Laundering Solution for 2003 and also for

2004. During the year 2004, i-flex opened its wholly owned holding company in US, namely

i-flex America, for carrying out all future acquisitions in the USA. The FLEXCUBE 10.0 was

released in 2007, it helps financial institutions respond faster to market dynamics and define

and track processes, while ensuring compliance. The suite also equipped with SWIFT 2007

enhancements and supports SEPA payment processing. New Version of FLEXCUBE Core

Banking for IBM System z active from April 2008. During August of the year 2008, the

company changed its name from I-flex solutions Limited to Oracle Financial Services

Software Limited. FLEXCUBE, Reveleus, Daybreak, Mantas, PrimeSourcing, i-flex

Consulting and iPFB are trademarks of i-flex solutions and are registered in several countries.

Together, Oracle and i-flex solutions offer financial services institutions the world's most


29/35

comprehensive and contemporary banking applications and want to embark technology

footprint that address their complex IT and business requirements.

Products and services

Oracle Financial Services Software Limited has two main streams of business. The products

division (formerly called BPD Banking products Division) and PrimeSourcing. The

company's offerings cover retail, corporate and investment banking, funds, cash management,

trade, treasury, payments, lending, private wealth management, asset management and

business analytics. The company undertook a rebranding exercise in the latter half of 2008.

As part of this, the corporate website was integrated with Oracle's website and various

divisions, services and products renamed to reflect the new identity post alignment with

Oracle.

Recently,Oracle Financial Services launched products for Internal Capital Adequacy

Assessment Process, exposure management, enterprise performance management and energy

and commodity trading compliance.


30/35

Markowitz Model

Markowitz used mathematical programming and statistical analysis in order to arrange for the

optimum allocation of assets within the portfolio. To reach this objective, Markowitz

generated portfolios within a reward-risk context.

Markowitzs model is a theoretical framework for the analysis of risk return choices.

Decisions are based on the concept of efficient portfolios.

To select efficient portfolio, according to Markowitz model we should select the securities

which have maximum return at given level of risk and at the same time these securities

should also be less co-related with each other. So, that change in the value of one security

does not bring change in the value of another security in order to minimise the risk of fall in

the value of portfolio. So, first of all here we have to identify minimum co-related securities

i.e. securities with minimum co-relation. And then we will find the return and risk for the

particular portfolio.

CORRELATION MATRIX:-

j & k SBI PFIZER SANOFI INFOSYS

ORACLE

FIN.

j & k 1

SBI 0.349271 1

PFIZER 0.044438 0.128079 1

SANOFI 0.107688 0.073373 0.223212 1

INFOSYS 0.096326 0.180063 -0.03688 -0.0046 1ORACLE

FIN. 0.124189 0.204217 0.163451 0.01977 0.186886 1

According to Markowitz model, the securities which have least correlation will beselected to construct portfolio. In this case, two securities INFOSYS LTD and PFIZER LTD

are selected because the correlation between them is -0.03688 which is least among all

other combination.


31/35

INFOSYS PFIZER

MEAN -0.06191 0.040614

SD 1.663844 1.226037

VARIANCE 2.768378 1.503168

CORELATION -0.03688

Calculation of weightage:

Wx = 2yx* y* rxy

2x +

2y2 *x*x*rxy

WX=0.356942

Wy = 1 - wx

= 1 - 0.356942

WY = 0.643058

Portfolio Risk:

2p = w

2X

2X + w

2Y

2Y + 2wx

wyrxyx

y

2p = 0.939768

p = 0.969417


32/35

Portfolio Return:Rp= WxRx+ WyRy

Where, Rp= Return of portfolio

w= Weight of security

R=Return of security

w

Expected

Return (R)

W

Expected

return

Infosys(x) 0.356942 -0.06191 -0.0221

Pfizer (Y) 0.643058 0.040614

+

0.026117

= Portfolio Return(RP) 0.00402

Interpretation:

As we have evaluated INFOSYS LTD and PFIZER LTDand found that the returns are low

(0.00402) & risk is (0.1044) which means money invested in these company will not fetch

returns as per investors expected return. We have very low return for given two securities. So

the investor should avoid investing in these companies. And if investor is keen to invest in

these sectors then he should invest in these two companies in order to maximize return and

minimise risk.

If investor is willing to take higher risk and have some strong internal information about the

companies which can increase the market value of the company then only investor should

invest in that company.

Now, if we look at the other possible combination having less co-relation we can find that

INFOSYS LTD and SANOFI INDIA LTD ltd having co-relation of -0.0046 which is also

near that of INFOSYS LTD AND PFIZER LTD . So, we can also build our portfolio by


33/35

considering these two securities. So, now we will calculate risk and return for both these

companies.

Calculation of weightage:

Wx = 2yx* y* rxy

2x +

2y2 *x*y*rxy

= (1.364)2(1.66)*(1.364)*(-0.0046)

(1.66)2+ (1.364)

22*(1.66) (1.364) (-0.0046)

wx = 0.404472

Wy = 1 - wx

= 1 - 0.404472

INFOYSIS(x) SANOFI(y)

Mean -0.061907017 0.007351569

S.D 1.66 1.364

Variance(2) 2.768378026 1.860885927

RXY -0.0046


34/35

Wy= 0.595528

Portfolio Risk:

2p = w2X2X + w2Y2Y + 2wX wY rXY XY

2p = 1.107

p = 1.0525

Portfolio Return:

w Expected Return

(R)

W

Expected

return

INFOYSIS.(x) 0.40 -0.0619 -0.02476

SANOFI(y) 0.60 0.007352 0.004411

Portfolio Return(RP)

=

-0.02035

Interpretation:

As we have evaluated INFOSYS LTD & SANOFI INDIA LTD and found that the returns are

negative (-0.02035) & risk is (1.0525) which means money invested in these company will

not fetch returns as per investors expected return. We have negative return for given two

securities. So the investor should avoid investing in these companies. And if investor is keen

to invest in these sectors then he should invest in these two companies in order to maximize

return and minimise risk than to previous two companies which are INFOSYS LTD AND

PFIZER LTD. As these two companies have higher return than previous two companies

against minor increase in risk and co-relation between these two securities. So, if investor is

not more risk adverse than he can invest in these companies in order to minimise his loss.


35/35

If investor is willing to take higher risk and have some strong internal information about the

companies which can increase the market value of the company then only investor should

invest in these companies.

Date post:	04-Jun-2018
Category:	Documents
Upload:	zalak-shah
View:	241 times
Download:	0 times

eps of it banking companies

Documents